124 related articles for article (PubMed ID: 14709354)
1. Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway.
Castro C; Campistol JM; Sancho D; Sánchez-Madrid F; Casals E; Andrés V
Atherosclerosis; 2004 Jan; 172(1):31-8. PubMed ID: 14709354
[TBL] [Abstract][Full Text] [Related]
2. Selective inactivation of p27(Kip1) in hematopoietic progenitor cells increases neointimal macrophage proliferation and accelerates atherosclerosis.
Díez-Juan A; Pérez P; Aracil M; Sancho D; Bernad A; Sánchez-Madrid F; Andrés V
Blood; 2004 Jan; 103(1):158-61. PubMed ID: 14504088
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.
Gallo R; Padurean A; Jayaraman T; Marx S; Roque M; Adelman S; Chesebro J; Fallon J; Fuster V; Marks A; Badimon JJ
Circulation; 1999 Apr; 99(16):2164-70. PubMed ID: 10217658
[TBL] [Abstract][Full Text] [Related]
4. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration.
Sun J; Marx SO; Chen HJ; Poon M; Marks AR; Rabbani LE
Circulation; 2001 Jun; 103(24):2967-72. PubMed ID: 11413088
[TBL] [Abstract][Full Text] [Related]
5. The growth suppressor p27(Kip1) protects against diet-induced atherosclerosis.
Díez-Juan A; Andrés V
FASEB J; 2001 Sep; 15(11):1989-95. PubMed ID: 11532979
[TBL] [Abstract][Full Text] [Related]
6. Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model.
Roqué M; Reis ED; Cordon-Cardo C; Taubman MB; Fallon JT; Fuster V; Badimon JJ
Lab Invest; 2001 Jun; 81(6):895-903. PubMed ID: 11406650
[TBL] [Abstract][Full Text] [Related]
7. Atheroma development in apolipoprotein E-null mice is not regulated by phosphorylation of p27(Kip1) on threonine 187.
Sanz-González SM; Melero-Fernández de Mera R; Malek NP; Andrés V
J Cell Biochem; 2006 Mar; 97(4):735-43. PubMed ID: 16229012
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis.
Pakala R; Stabile E; Jang GJ; Clavijo L; Waksman R
J Cardiovasc Pharmacol; 2005 Oct; 46(4):481-6. PubMed ID: 16160601
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.
Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V
J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model.
Carter AJ; Aggarwal M; Kopia GA; Tio F; Tsao PS; Kolata R; Yeung AC; Llanos G; Dooley J; Falotico R
Cardiovasc Res; 2004 Sep; 63(4):617-24. PubMed ID: 15306217
[TBL] [Abstract][Full Text] [Related]
11. The homeostasis but not the differentiation of T cells is regulated by p27(Kip1).
Shen R; Kaplan MH
J Immunol; 2002 Jul; 169(2):714-21. PubMed ID: 12097373
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression.
Woltman AM; van der Kooij SW; Coffer PJ; Offringa R; Daha MR; van Kooten C
Blood; 2003 Feb; 101(4):1439-45. PubMed ID: 12393532
[TBL] [Abstract][Full Text] [Related]
13. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy.
Luan FL; Hojo M; Maluccio M; Yamaji K; Suthanthiran M
Transplantation; 2002 May; 73(10):1565-72. PubMed ID: 12042641
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice.
Poolman RA; Li JM; Durand B; Brooks G
Circ Res; 1999 Jul; 85(2):117-27. PubMed ID: 10417393
[TBL] [Abstract][Full Text] [Related]
17. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.
Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE
Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice.
Elloso MM; Azrolan N; Sehgal SN; Hsu PL; Phiel KL; Kopec CA; Basso MD; Adelman SJ
Am J Transplant; 2003 May; 3(5):562-9. PubMed ID: 12752312
[TBL] [Abstract][Full Text] [Related]
19. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
[TBL] [Abstract][Full Text] [Related]
20. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
